Issues
Is THIS the Vaccine to Stop Covid?
A new vaccine may be the most effective to fight the coronavirus. Moderna (NASDAQ: MRNA) just announced initial results from vaccine. The Moderna vaccine is 94.5% effective in protecting… Read more
Read more »Pfizer Versus Moderna: Who Has the Best Vaccine
There is more excellent news on Covid vaccines today: Moderna (NASDAQ: MRNA) said its Covid-19 vaccine had shown 94.5% efficacy in clinical trials. The company’s CEO, Stéphane Bancel, said… Read more
Read more »Investment Advice from the Federal Reserve Bank
Mental health is emerging as a major concern as Covid-19 spreads through the population. The latest worry came from a study a study published in The Lancet Psychiatry journal…. Read more
Read more »IPO Alert: DoorDash Releases Confidential IPO Filing
DoorDash, the biggest meal-delivery company in the U.S., released its confidential IPO details in an SEC filing today. The DoorDash IPO is expected by year-end. Shares could pop 30%… Read more
Read more »CDC Issues New Guidance
The promising vaccine under testing by Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) also highlights some big issues around vaccine distribution. The vaccine has to be stored at -70… Read more
Read more »Trump Delays Airbnb IPO
Bloomberg reports on the Airbnb IPO that . . . Airbnb said to delay IPO filing to distance it from election. The 2020 presidential election continues to dominate the… Read more
Read more »Why Kids Are Less Likely to Get Sick
Scientists have been puzzled as to why children are less affected by Covid-19. Now, a controversial study may have found the answer. According to researchers at the Francis Crick… Read more
Read more »The Top 10: Most Profitable IPOs in 2020
2020 is the year of the Initial Public Offering or IPO. 184 private companies have already gone public. And these newly public companies raised a staggering $63.7 billion from… Read more
Read more »Pfizer Vaccine: Will It Be Safe?
We definitely had great news yesterday on the novel coronavirus vaccine being developed by Pfizer (NYSE: PFE) and Germany’s BioNTech (NASDAQ: BNTX). Let’s assume the Pfizer vaccine is approved…. Read more
Read more »